MYL Shares Outstanding History
Below is a table of the MYL shares outstanding history going back to 2/19/2010:

Date MYL Shares Outstanding
2/19/2010306.68M
4/28/2010308.85M
7/26/2010309.36M
10/22/2010309.73M
2/17/2011437.06M
4/27/2011439.25M
7/20/2011426.26M
10/20/2011426.51M
2/15/2012426.93M
4/19/2012428.65M
7/20/2012405.89M
10/19/2012407.53M
2/25/2013395.55M
4/29/2013381.09M
7/29/2013381.81M
10/25/2013382.86M
2/21/2014371.91M
4/25/2014373.73M
8/1/2014374.05M
10/29/2014374.27M
12/23/2014375.03M
2/24/2015378.37M
5/1/2015490.03M
8/3/2015491.55M
10/28/2015491.75M
2/8/2016490.69M
4/27/2016508.34M
8/5/2016534.91M
11/4/2016535.11M
2/24/2017535.50M
4/26/2017535.95M
5/4/2017535.95M
8/4/2017536.28M
11/2/2017536.44M
2/23/2018514.78M
4/25/2018515.42M
8/3/2018515.57M
10/31/2018515.63M
2/22/2019515.95M
4/25/2019515.42M
5/1/2019515.44M
7/23/2019515.87M
7/15/2019165.56M
10/31/2019516.13M

Also see: MYL Market Cap History
and MYL YTD Return
MYL Historical Shares Outstanding:
+5.51% CAGR
MYL Historical Shares Outstanding: +5.51% CAGR

Mouse over chart for data details
2/19/2010 ...10/31/2019
Mylan is engaged in the global development, licensing, manufacturing, marketing and distributing generic, branded generic, brand-name and over-the-counter pharmaceutical products for resale by others and active pharmaceutical (API) ingredients through three segments, North America, Europe and Rest of World. Co.'s API business is conducted through its subsidiary, Mylan Laboratories Limited. North America segment comprises operations in the U.S. and Canada. Europe segment encompasses operations across countries, including France, Italy, Germany, the U.K. and Spain. Rest of World segment reflects operations in countries outside of its North America and Europe segments. We show 44 historical shares outstanding datapoints in our coverage of MYL's shares outstanding history.

Understanding the changing numbers of MYL shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MYL versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MYL by allowing them to research MYL shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for MYL:
MYL SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Mylan NV (MYL) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

MYND Shares Outstanding History
MYOK Shares Outstanding History
NAOV Shares Outstanding History
NBIX Shares Outstanding History
NDRA Shares Outstanding History
NEO Shares Outstanding History
NEOG Shares Outstanding History
NEOS Shares Outstanding History
NERV Shares Outstanding History
NK Shares Outstanding History
More Healthcare companies »

 

MYL Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2019, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.